• The University of Western Australia (M582), 35 Stirling Highway,

    6009 Perth


  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
If you made any changes in Pure these will be visible here soon.

Personal profile


Andy Redfern is Associate Professor of Medical Oncology at the University of Western Australia, Associate Director for Clinical Strategy at Harry Perkins Institute of Medical Research, Consultant Medical Oncologist at the Fiona Stanley Hospital, Perth, and Medical Director of Linear Clinical Research specialising in early phase human trials.

Beyond a clinical practice treating breast and urological cancers, Andy is principal investigator for a range of clinical trials across all phases and has a portfolio of translational research initiatives. His research interests centre around growth signalling and mechanisms of chemotherapy and hormone therapy resistance in cancer, differentiation and EMT in cancer progression, tumour-stroma interactions and Indigenous cancer biology.

Andy is also chairman and lead clinician of the State Breast Cancer Collaborative and is on scientific advisory boards for the Cancer Council of Western Australia and the Australasian Breast Cancer Trials Group.

Research expertise keywords

  • cancer growth signalling
  • chemotherapy resistance
  • hormone therapy resistance
  • cancer progression
  • tumour-stroma interactions


Dive into the research topics where Andrew Redfern is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or